Your browser doesn't support javascript.
The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing.
Klepser, Donald G; Klepser, Nicklas S; Adams, Jennifer L; Adams, Alex J; Klepser, Michael E.
  • Klepser DG; College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Klepser NS; Kalamazoo College, Kalamazoo, MI, USA.
  • Adams JL; College of Pharmacy, Idaho State University, Meridian, Idaho, USA.
  • Adams AJ; Financial Management, Idaho Division of Financial Management, Boise, Idaho, USA.
  • Klepser ME; Pharmacy Practice, College of Pharmacy, Ferris State University, Kalamazoo, Michigan, USA.
Expert Rev Mol Diagn ; 21(8): 751-755, 2021 08.
Article in English | MEDLINE | ID: covidwho-1269466
ABSTRACT

Introduction:

Pharmacy-based point-of-care testing has long had the potential to improve patient access to timely care, but adoption has been slowed by financial and regulatory barriers. The COVID-19 pandemic reduced or temporarily eliminated many of the barriers to pharmacy-based testing. This review examines how the changes brought on by may impact pharmacy-based testing after the pandemic.Areas covered This review searched peer-reviewed, lay, and regulatory literature to explore the implementation of pharmacy-based COVID-19 testing. This includes a review of regulatory and financial changes that removed barriers to testing. Additionally, it reviews the literature related to the growth of pharmacy-based testing.Expert opinion It is clear that the COVID-19 pandemic created an awareness and opportunity for pharmacy-based point-of-care testing. The changes made in response to the pandemic have the potential to increase the role of pharmacy-based testing, but additional regulatory changes and wider pharmacy adoption are still needed to maximize the value of such services.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Community Pharmacy Services / Point-of-Care Testing / COVID-19 Testing Type of study: Diagnostic study / Experimental Studies / Observational study Limits: Humans Language: English Journal: Expert Rev Mol Diagn Journal subject: Molecular Biology Year: 2021 Document Type: Article Affiliation country: 14737159.2021.1944105

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Community Pharmacy Services / Point-of-Care Testing / COVID-19 Testing Type of study: Diagnostic study / Experimental Studies / Observational study Limits: Humans Language: English Journal: Expert Rev Mol Diagn Journal subject: Molecular Biology Year: 2021 Document Type: Article Affiliation country: 14737159.2021.1944105